| Mr Brad C Wilson, DPT,ATC | |
|
1301 A Harrison Ave, Professional Rehab Associates, Mccomb, MS 39648 | |
| (601) 250-5455 | |
| (601) 250-5453 |
| Full Name | Mr Brad C Wilson |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 23 Years |
| Location | 1301 A Harrison Ave, Mccomb, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093011595 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | MSPT3350 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Professional Rehab Associates | 2567648777 | 7 |
News Archive
Genzyme Corporation today reported five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial. This sub-group analysis found that nearly 90 percent of alemtuzumab-treated patients were free of sustained accumulation of disability, and that patients receiving alemtuzumab also maintained improved mean disability scores and a low risk of relapse over the 60-month follow-up period.
"Papua New Guinea is a Pacific country rich in natural resources, yet its health staffing levels are comparable to the world's poorest countries due to a rapidly retiring force and lack of qualified replacements," IRIN reports.
Medtronic, Inc. today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour 3D™ Annuloplasty Ring, the device is designed to restore normal valve function by remodeling the natural valve's shape and size. The Contour 3D Ring is approved for use in the U.S., Europe and several other countries.
Vaxin Inc., a privately-held biotechnology company, has demonstrated, in a Phase I human clinical study, that the company's recombinant influenza vaccine provides a potential alternative to traditional flu vaccines.
A.P. Pharma, a specialty pharmaceutical company, today announced that on October 26, 2009, the Company received notice that the Nasdaq Listing Qualifications Panel (Panel) has granted the Company's request to transfer the listing of the Company's common stock from The Nasdaq Global Market to The Nasdaq Capital Market, which will take effect with the opening of the market on Wednesday, October 28, 2009.
› Verified 5 days ago
| Provider Name | Professional Rehab Associates |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1801192307 PECOS PAC ID: 2567648777 Enrollment ID: O20110523000605 |
News Archive
Genzyme Corporation today reported five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial. This sub-group analysis found that nearly 90 percent of alemtuzumab-treated patients were free of sustained accumulation of disability, and that patients receiving alemtuzumab also maintained improved mean disability scores and a low risk of relapse over the 60-month follow-up period.
"Papua New Guinea is a Pacific country rich in natural resources, yet its health staffing levels are comparable to the world's poorest countries due to a rapidly retiring force and lack of qualified replacements," IRIN reports.
Medtronic, Inc. today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour 3D™ Annuloplasty Ring, the device is designed to restore normal valve function by remodeling the natural valve's shape and size. The Contour 3D Ring is approved for use in the U.S., Europe and several other countries.
Vaxin Inc., a privately-held biotechnology company, has demonstrated, in a Phase I human clinical study, that the company's recombinant influenza vaccine provides a potential alternative to traditional flu vaccines.
A.P. Pharma, a specialty pharmaceutical company, today announced that on October 26, 2009, the Company received notice that the Nasdaq Listing Qualifications Panel (Panel) has granted the Company's request to transfer the listing of the Company's common stock from The Nasdaq Global Market to The Nasdaq Capital Market, which will take effect with the opening of the market on Wednesday, October 28, 2009.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Brad C Wilson, DPT,ATC 1301 A Harrison Ave, Mccomb, MS 39648 Ph: (601) 250-5455 | Mr Brad C Wilson, DPT,ATC 1301 A Harrison Ave, Professional Rehab Associates, Mccomb, MS 39648 Ph: (601) 250-5455 |
News Archive
Genzyme Corporation today reported five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial. This sub-group analysis found that nearly 90 percent of alemtuzumab-treated patients were free of sustained accumulation of disability, and that patients receiving alemtuzumab also maintained improved mean disability scores and a low risk of relapse over the 60-month follow-up period.
"Papua New Guinea is a Pacific country rich in natural resources, yet its health staffing levels are comparable to the world's poorest countries due to a rapidly retiring force and lack of qualified replacements," IRIN reports.
Medtronic, Inc. today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour 3D™ Annuloplasty Ring, the device is designed to restore normal valve function by remodeling the natural valve's shape and size. The Contour 3D Ring is approved for use in the U.S., Europe and several other countries.
Vaxin Inc., a privately-held biotechnology company, has demonstrated, in a Phase I human clinical study, that the company's recombinant influenza vaccine provides a potential alternative to traditional flu vaccines.
A.P. Pharma, a specialty pharmaceutical company, today announced that on October 26, 2009, the Company received notice that the Nasdaq Listing Qualifications Panel (Panel) has granted the Company's request to transfer the listing of the Company's common stock from The Nasdaq Global Market to The Nasdaq Capital Market, which will take effect with the opening of the market on Wednesday, October 28, 2009.
› Verified 5 days ago
Judy Thibodeaux, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 206 Maryland Ave, Mccomb, MS 39648 Phone: 601-250-4815 Fax: 601-250-6859 | |
Emily Troxler, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 501 S Locust St, Mccomb, MS 39648 Phone: 601-684-8111 | |
Taneshia Jones, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 S Locust St, Mccomb, MS 39648 Phone: 601-684-8111 | |
Nigelia Williams, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 206 Maryland Ave, Mccomb, MS 39648 Phone: 601-250-4815 | |
Karen Alicia Hart, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1301a Harrison Ave, Mccomb, MS 39648 Phone: 601-250-5455 Fax: 601-250-5453 | |
Enid Poche Smith, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 206 Maryland Ave, Mccomb, MS 39648 Phone: 601-250-4815 |